Skip to main content
Premium Trial:

Request an Annual Quote

Berkeley HeartLab Using GenTegra DNA

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celera subsidiary Berkeley HeartLab will use GenVault's biosample preservation and storage technology for use in its clinical lab testing business, GenVault said today.

GenVault's GenTegra DNA technology is used to stabilize purified DNA biosamples with antimicrobial activity for dry, room temperature transport and biobanking. Purified DNA dried within the GenTegra DNA platform is fully resolubilized with water for direct downstream molecular analysis, the company said.

The platform is a scalable and environmentally friendly alternative to freezers and nucleic acid purification systems, and enables the extraction, preservation, recovery, and distribution of biosamples at ambient temperature, Carlsbad, Calif.-based GenVault said.

Financial terms of the agreement were not released.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.